(BAM15) This drug will revolutionize weight loss! (GTFIH)

[Rigged]

Been knowing and up to date with this for a few years its finally starting to get sourced, not sure on when exactly but my guesses is between late 2024 or early 2025

Gonna make a breakdown on it when it starts getting sourced on the gray market

What it is:
In the simplest terms it does what DNP does but better while being 10x safer

It doesnt have extreme, ROS production or hyperthermia, also greater mitochondrial specificity, so u avoid the off target damage that happens with DNP
Not just that its less toxic so you can have way longer cycles compared to other mitochondrial uncouplers

Pricing:
Not sure yet getting it from lab would be around $100 for a months supply, so my guess is depending on a few factors
1. How high in demands it is
2. How many producers get in early

Thats pretty much it, my guess is at the start maybe for a year itll be an insane price ranging from 500-1000 a month but when more producers get and the demand goes down they will lower the price to around 100-200, kinda like what happened with BPC-157 and TB-500

 

[Rigged]

@Donkeyballs

 

[Rigged]

@oppastoppathe2nd @4lt.Real @MA_ascender @JohnDoe @Youㅤ

 

[MA_ascender]

Reading...

 

[Dyorotic]

The selectivity is fucking astounding, game changer. DNP might actually get dethroned which I never thought would have happened

 

[ItsOverLawg]

don't let white women see this

 

[Dyorotic]

I doubt It'd be hard to source. Just purchase from Chinese companies and send samples to Janoshik.

 

[Rigged]

The selectivity is fucking astounding, game changer. DNP might actually get dethroned which I never thought would have happened

when i first read about it i dmd all my private sources to see if they had it, its was so impossible to find any, now that its going out soon im so excited, theres another thing im 100x more excited about ima keep down low for now, but as a hint it could replace testosterone (steroid)

 

[Rigged]

I doubt It'd be hard to source. Just purchase from Chinese companies and send samples to Janoshik.

The issue isnt how hard it is too make its just no one knew about it so no one wanted it

 

[MA_ascender]

Mogger compound icl





Still waiting on fucking GHRH and GHRPs I hate my life

 

[Donkeyballs]

Do you think it will overtake other compounds like semaglutide (ozempic)?

Also what do you think about retatrutide which is also quite recent and still in clinical trials, but sources already exist.
retatrutide targets serveral hunger regulating factors unlike other drugs, it activates GLP-1 (like ozempic) but also induces GIP receptor activation and glucagon receptors.
Retatrutide:
Retatrutide caused -24.2% weight loss in 48 weeks at 12mg which is crazy compared to ozempic.

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

The least-squares mean percentage change in body weight at 24 weeks in the retatrutide groups was -7.2% in the 1-mg group, -12.9% in the combined 4-mg group, -17.3% in the combined 8-mg group, and -17.5% in the 12-mg group, as compared with -1.6% in the placebo group. At 48 weeks, the least-squares mean percentage change in the retatrutide groups was -8.7% in the 1-mg group, -17.1% in the combined 4-mg group, -22.8% in the combined 8-mg group, and -24.2% in the 12-mg group, as compared with -2.1% in the placebo group.

Ozempic caused reduction of around %15 weight in 68 weeks

Semaglutide for the treatment of obesity - PubMed

Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the US Food and Drug Administration for chronic weight management. This paper reviews data on the mechanism of action, weight-loss and cardiometabolic efficacy, and safety of semaglutide 2.4 mg/week for...

pubmed.ncbi.nlm.nih.gov

.Semaglutide has demonstrated the largest weight loss of any obesity medication to date with reductions of approximately 15% of initial weight at 68 weeks,

meanwhile another study states that ozempic had around %6 mean weight loss after 3 months with weeky injections

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

The study included 175 patients (132 women [75.4%]; mean [SD] age, 49.3 [12.5] years; mean [SD] BMI, 41.3 [9.1]) in the analysis at 3 months and 102 patients at 6 months. The mean (SD) weight loss after 3 months was 6.7 (4.4) kg, equivalent to a mean (SD) weight loss of 5.9% (3.7%) (P < .001), and the mean (SD) weight loss after 6 months was 12.3 (6.6) kg, equivalent to a mean (SD) weight loss of 10.9% (5.8%) (P < .001 from baseline). Of the 102 patients who were followed up at 6 months, 89 (87.3%) achieved weight loss of 5% or more, 56 (54.9%) achieved weight loss of 10% or more, 24 (23.5%) achieved weight loss of 15% or more, and 8 (7.8%) achieved weight loss of 20% or more. Patients with type 2 diabetes had a lower mean (SD) percentage weight loss at 3 and 6 months compared with those without type 2 diabetes: 3.9% (3.1%) vs 6.3% (3.7%) at 3 months (P = .001) and 7.2% (6.3%) vs 11.8% (5.3%) at 6 months (P = .005).

 

[MA_ascender]

Do you think it will overtake other compounds like semaglutide (ozempic)?

Also what do you think about retatrutide which is also quite recent and still in clinical trials, but sources already exist.
retatrutide targets serveral hunger regulating factors unlike other drugs, it activates GLP-1 (like ozempic) but also induces GIP receptor activation and glucagon receptors.
Retatrutide:
Retatrutide caused -24.2% weight loss in 48 weeks at 12mg which is crazy compared to ozempic.

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

Ozempic caused reduction of around %15 weight in 68 weeks

Semaglutide for the treatment of obesity - PubMed

Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the US Food and Drug Administration for chronic weight management. This paper reviews data on the mechanism of action, weight-loss and cardiometabolic efficacy, and safety of semaglutide 2.4 mg/week for...

pubmed.ncbi.nlm.nih.gov

meanwhile another study states that ozempic had around %6 mean weight loss after 3 months with weeky injections

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

Tirz mogs almost everything ngl I follow this Chinese supplier and they post some before afters

 

[Donkeyballs]

Tirz mogs almost everything ngl I follow this Chinese supplier and they post some before afters

Honestly tirzepatide is up there with retatrutide and probably better than ozempic too, also dosent have much sides.
Selank is milder but increases serotonin, mazdutide is also very similar to retatrutide, they are both made by Eli Lilly

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity - Nature Communications

Mazdutide is a once-weekly glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. Here, the authors show mazdutide was well tolerated over 24 weeks and demonstrated significant and clinically meaningful body weight loss, compared with placebo, in Chinese overweight adults or adults...

www.nature.com

week 24 in body weight were −6.7% (SE 0.7) with mazdutide 3 mg, −10.4% (0.7) with 4.5 mg, −11.3% (0.7) with 6 mg

I would consider tirzepatide and retatrutide currently as one of the best avaible weight loss drugs

 

[MA_ascender]

Honestly tirzepatide is up there with retatrutide and probably better than ozempic too, also dosent have much sides.
Selank is milder but increases serotonin, mazdutide is also very similar to retatrutide, they are both made by Eli Lilly

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity - Nature Communications

Mazdutide is a once-weekly glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. Here, the authors show mazdutide was well tolerated over 24 weeks and demonstrated significant and clinically meaningful body weight loss, compared with placebo, in Chinese overweight adults or adults...

www.nature.com

I would consider tirzepatide and retatrutide currently as one of the best avaible weight loss drugs

Your average looksmax Joe shouldn't bother with GLP-1s. Fat burners would be better, this one seems promising if it can take DNP's place

 

[Rigged]

Do you think it will overtake other compounds like semaglutide (ozempic)?

Not really, its more niche and they work differently one works thru satiety and glucose regulation the other enhances metabolic inefficiency

if anything theyd be complimentary rather than competitive

Also what do you think about retatrutide which is also quite recent and still in clinical trials, but sources already exist.
retatrutide targets serveral hunger regulating factors unlike other drugs, it activates GLP-1 (like ozempic) but also induces GIP receptor activation and glucagon receptors.

Retatrutide:
Retatrutide caused -24.2% weight loss in 48 weeks at 12mg which is crazy compared to ozempic.

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

Ozempic caused reduction of around %15 weight in 68 weeks

Semaglutide for the treatment of obesity - PubMed

Semaglutide is a glucagon-like peptide-1 receptor agonist that was recently approved by the US Food and Drug Administration for chronic weight management. This paper reviews data on the mechanism of action, weight-loss and cardiometabolic efficacy, and safety of semaglutide 2.4 mg/week for...

pubmed.ncbi.nlm.nih.gov

meanwhile another study states that ozempic had around %6 mean weight loss after 3 months with weeky injections

Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial - PubMed

In adults with obesity, retatrutide treatment for 48 weeks resulted in substantial reductions in body weight. (Funded by Eli Lilly; ClinicalTrials.gov number, NCT04881760.).

pubmed.ncbi.nlm.nih.gov

Comparing them doesnt really
BAM and Ret dont relate at all, one causes weight loss the other just reduces ur appetite

 

[Rigged]

Honestly tirzepatide is up there with retatrutide and probably better than ozempic too, also dosent have much sides.

I wouldnt say so, the inclusion of glucagon receptors increases energy expenditure thru boosting fat oxidation, tirz cant achieve this cause of its lack of the third pathway

Selank is milder but increases serotonin, mazdutide is also very similar to retatrutide, they are both made by Eli Lilly

Selank has no place in a convo about weight loss, serotonin regulation has some influence over mood and indirectly stress related eating but its not comparable to appetite suppressors/ metabolic enhancers u get with GLP-1 agonists, its a mood enhancer not a fat burner

A phase 2 randomised controlled trial of mazdutide in Chinese overweight adults or adults with obesity - Nature Communications

Mazdutide is a once-weekly glucagon-like peptide-1 (GLP-1) and glucagon receptor dual agonist. Here, the authors show mazdutide was well tolerated over 24 weeks and demonstrated significant and clinically meaningful body weight loss, compared with placebo, in Chinese overweight adults or adults...

www.nature.com

Abt maz sure its a dual agonist like tirz, but it’s still worse than ret, the results from the Chinese trials are great tho

I would consider tirzepatide and retatrutide currently as one of the best avaible weight loss drugs

The best weight loss drugs need to go beyond just regulating hunger they need to accelerate fat oxidation

 

[Rigged]

Your average looksmax Joe shouldn't bother with GLP-1s. Fat burners would be better, this one seems promising if it can take DNP's place

Your average looksmaxer should be spending his money on escorts and prostitutes not fatburners from ling lings labratory